Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Big Picture Summary Retatrutide peptide is a triple-agonist compound (GLP-1, GIP, glucagon) developed by Eli Lilly , showing next-generation potential for weight loss and metabolic health
Instruct patients to inform healthcare providers prior to any planned surgeries or procedures if they are taking RYBELSUS or OZEMPIC tablets [see Warnings and Precautions (5.9)]
Over a six-month treatment period, the total cost projection for tirzepatide through Willow averages approximately $2,719, or roughly $453 per month when accounting for dose escalation
Diabetes Drugs in the Fight Against Alzheimers Disease
When medications first launch, prices sit higher
US$ 26.18
US$ 24.84
US$ 21.33
US$ 26.68
US$ 25.35
US$ 28.71
